Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Diakron Pharmaceuticals

1998 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of cardiovascular drug. The company is engaged in drug discovery for cardiovascular related fields. It has development programs targeting clotting disorders, hypertension and diabetes.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Parent Company
Primary Office
  • P.O. Box 748
  • Morris Plains, NJ 07950
  • United States

Diakron Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Diakron Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Diakron Pharmaceuticals Executive Team (5)

Name Title Board
Seat
Contact
Info
Richard Chenot Chief Financial Officer
Robert Anderson Chief Marketing Officer
Srirama Rao Ph.D Chairman, Chief Scientific Officer & Co-Founder
Stephane Allard MD Chief Medical Officer
Martin Cearnal President & Chief Executive Officer